Total Funding
13
Total FundingConvertible Note raised
Growth Score
pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
RhinoCyte develops and commercializes diagnostic tools and therapies for the stem cell treatment of neurological diseases.
Fred Roisen: Owner
About the Company
RhinoCyte engages in the development and commercialization of diagnostic tools and therapies for stem cell treatment of multiple degenerative and traumatic neurological diseases. Its technology facilitates functional recovery in patients, including therapeutic stem cell transplantation with cells from the patient's own nasal cavity eliminating
the need for immunosuppressive therapy. The company's technology is used to treat conditions, such as Parkinson's disease, Multiple Sclerosis, Alzheimer's disease, and spinal cord injuries. RhinoCyte, Inc. was founded in 2005 and is based in Louisville, Kentucky.
Women Led
